These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 20417486)

  • 41. [Determination of maternal serum alpha-fetoprotein and free beta human chorionic gonadotropin in twin pregnancies comparing to single pregnancies in the second trimester].
    Jin Y; Shen M; Lu SM
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2007 May; 23(2):147-9. PubMed ID: 21179754
    [No Abstract]   [Full Text] [Related]  

  • 42. Biochemical screening for Down syndrome in pregnancies following renal transplantation.
    Karidas CN; Michailidis GD; Spencer K; Economides DL
    Prenat Diagn; 2002 Mar; 22(3):226-30. PubMed ID: 11920899
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of mild hepatic or renal impairment on maternal serum screening biochemical measures.
    Ying I; Wyatt PR; Nisenbaum R; Ray JG
    J Obstet Gynaecol Can; 2011 Dec; 33(12):1218-1222. PubMed ID: 22166275
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of antiphospholipid biology in maternal Down syndrome screening.
    Brochet C; Morin N; Coudert M; Vauthier-Brouzes D; Costedoat-Chalumeau N; Bernard M
    Prenat Diagn; 2009 May; 29(5):481-8. PubMed ID: 19226525
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of novel candidate maternal serum protein markers for Down syndrome by integrated proteomic and bioinformatic analysis.
    Kang Y; Dong X; Zhou Q; Zhang Y; Cheng Y; Hu R; Su C; Jin H; Liu X; Ma D; Tian W; Li X
    Prenat Diagn; 2012 Mar; 32(3):284-92. PubMed ID: 22430729
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Maternal serum free beta hCG screening: results of studies including 480 cases of Down syndrome--problems with this approach.
    Wierzbicki AS
    Prenat Diagn; 1994 Nov; 14(11):1093; author reply 1094-5. PubMed ID: 7533287
    [No Abstract]   [Full Text] [Related]  

  • 47. Biochemical screening for Down syndrome in renal failure.
    Lam CM; Wong SF; Chow KM
    Am J Obstet Gynecol; 2003 Feb; 188(2):597; author reply 597. PubMed ID: 12592277
    [No Abstract]   [Full Text] [Related]  

  • 48. Fetal obstructive uropathy complicated by urinary ascites: outcome and prognostic value of fetal serum β-2-microglobulin.
    Spaggiari E; Dreux S; Czerkiewicz I; Favre R; Schmitz T; Guimiot F; Laurichesse Delmas H; Verspyck E; Oury JF; Ville Y; Muller F
    Ultrasound Obstet Gynecol; 2013 Feb; 41(2):185-9. PubMed ID: 23090907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Abnormally elevated serum hCG in a patient with end-stage renal disease seeking abortion: to be expected or a cause for concern? A case report.
    Thompson BW; Zerden ML; Morse JE
    Contraception; 2015 Jul; 92(1):84-6. PubMed ID: 25858678
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Foetal serum but not urinary β2-microglobulin correlates with histological injury to the kidney.
    Luton D; Delezoide AL; Leguy MC; Gobeaux C; Vuillard E; Grangé G; Guibourdenche J
    Clin Biochem; 2013 Oct; 46(15):1607-10. PubMed ID: 23628594
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Biomedicalization: considering ethical issues in providing maternal serum screening].
    Chiang HH
    Hu Li Za Zhi; 2010 Dec; 57(6):18-23. PubMed ID: 21140340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low maternal serum alpha-fetoprotein and Down syndrome.
    Cuckle HS; Wald NJ
    Prenat Diagn; 1987 Oct; 7(8):611-2. PubMed ID: 2446311
    [No Abstract]   [Full Text] [Related]  

  • 53. A multifactorial relationship exists between total circulating cell-free DNA levels and maternal BMI.
    Vora NL; Johnson KL; Basu S; Catalano PM; Hauguel-De Mouzon S; Bianchi DW
    Prenat Diagn; 2012 Sep; 32(9):912-4. PubMed ID: 22717986
    [No Abstract]   [Full Text] [Related]  

  • 54. Beta HCG levels in a pregnant dialysis patient: a cautionary tale.
    Potluri K; Moldenhauer J; Karlman R; Hou S
    NDT Plus; 2011 Feb; 4(1):42-3. PubMed ID: 25984100
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kidney disease and reproductive health.
    Smith PA; Sarris I; Clark K; Wiles K; Bramham K
    Nat Rev Nephrol; 2024 Nov; ():. PubMed ID: 39501029
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Maternal and fetal outcomes of pregnancy in chronic kidney disease: diagnostic challenges, surveillance and treatment throughout the spectrum of kidney disease.
    Gouveia IF; Silva JR; Santos C; Carvalho C
    J Bras Nefrol; 2021; 43(1):88-102. PubMed ID: 33460427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Managing pregnancy in chronic kidney disease: improving outcomes for mother and baby.
    Fitzpatrick A; Mohammadi F; Jesudason S
    Int J Womens Health; 2016; 8():273-85. PubMed ID: 27471410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Down syndrome maternal serum screening in patients with renal disease.
    Benachi A; Dreux S; Kaddioui-Maalej S; Czerkiewicz I; Fakhouri F; Thervet E; Muller F
    Am J Obstet Gynecol; 2010 Jul; 203(1):60.e1-4. PubMed ID: 20417486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is maternal renal disease a cause of elevated free beta-hCG in first trimester aneuploidy screening?
    Spencer K; Enofe O; Cowans NJ; Stamatopoulou A
    Prenat Diagn; 2009 Nov; 29(11):1045-9. PubMed ID: 19670347
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adverse pregnancy outcomes after a false-positive second trimester serum screen for Down syndrome in Thai pregnant women.
    Sritippayawan S; Vachirasrisoontra C
    J Med Assoc Thai; 2005 Apr; 88(4):449-54. PubMed ID: 16146246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.